Standard Biotools Inc (LAB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 113,663 | 81,309 | 60,200 | 74,361 | 29,983 |
| Marketable Securities | 40,874 | 84,475 | 124,968 | 136,850 | N/A |
| Receivables | 14,504 | 17,280 | 17,294 | 10,937 | 15,422 |
| Inventories | 22,513 | 21,473 | 21,946 | 22,791 | 23,245 |
| TOTAL | $194,928 | $208,815 | $229,017 | $250,877 | $73,197 |
| Non-Current Assets | |||||
| PPE Net | 25,002 | 25,652 | 26,584 | 27,275 | 27,699 |
| Intangibles | 116,085 | 118,851 | 121,469 | 124,400 | 131,208 |
| Other Non-Current Assets | 35,639 | 36,992 | 37,845 | 38,570 | 39,834 |
| TOTAL | $176,726 | $181,495 | $185,898 | $190,245 | $198,741 |
| Total Assets | $371,654 | $390,310 | $414,915 | $441,122 | $271,938 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 3,333 | 2,083 | 833 | N/A | N/A |
| Accounts payable and accrued liabilities | 6,109 | 7,914 | 9,305 | 9,016 | 12,517 |
| Accrued Expenses | 8,430 | 9,153 | 10,624 | 8,576 | 7,964 |
| TOTAL | $43,787 | $43,443 | $46,169 | $42,770 | $47,173 |
| Non-Current Liabilities | |||||
| Long Term Debt | 7,001 | 8,194 | 9,386 | 10,162 | 45,761 |
| Deferred Revenues | 15,273 | 14,436 | 14,978 | 15,138 | 15,894 |
| Other Non-Current Liabilities | 88,434 | 89,657 | 90,539 | 91,413 | 130,317 |
| TOTAL | $113,767 | $117,081 | $120,240 | $124,553 | $202,652 |
| Total Liabilities | $157,554 | $160,524 | $166,409 | $167,323 | $249,825 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 78,385 | 79,064 | 79,296 | 78,655 | 77,252 |
| Common Shares | 80 | 80 | 79 | 79 | 77 |
| Retained earnings | -942,939 | -926,096 | -905,251 | -875,825 | -812,286 |
| Other shareholders' equity | 309,896 | 309,794 | 308,644 | 309,000 | -1,057 |
| TOTAL | $214,100 | $229,786 | $248,506 | $273,799 | $22,113 |
| Total Liabilities And Equity | $371,654 | $390,310 | $414,915 | $441,122 | $271,938 |